In line with the observed suppressing effect of BRAT1 on its expression, Cav-1 has been described to function as a putative tumor suppressor in GBM, further highlighting the notion of targeting BRAT1 to inhibit the migrative and invasive capacity of this tumor [75]. Here, BRAT1 is linked to glioblastoma.